Navigation Links
Genetic Engineering & Biotechnology News Reports on the Growing Role of Ion-Channel Studies in Global Biotech R&D
Date:6/4/2008

NEW ROCHELLE, N.Y., June 4 /PRNewswire/ -- Ion-channel research is drawing increasing attention from a wide variety of life science investigators all over the globe, reports Genetic Engineering and Biotechnology News (GEN). Such interest is not surprising as ion channels play key roles in numerous biological processes such as neural signal transduction, cardiac, skeletal, and smooth muscle contraction, and epithelial transport of nutrients and ions, among others, according to an article in the June 1 issue of GEN (http://www.genengnews.com/articles/chitem.aspx?aid=2484).

"Research on ion channels has opened up possibilities for new ways to treat a host of diseases, including cancer, a malfunctioning immune system, and cardiovascular and metabolic disorders," notes John Sterling, Editor in Chief of GEN.

On the basic research side, Merritt Maduke, PhD, assistant professor in the department of molecular and cellular physiology at Stanford University School of Medicine, has built a lab focused on elucidating the molecular mechanisms underlying the function of the CLC chloride channels, the largest molecular family of mammalian anion channels. Dr. Maduke's interest in the CLC family is that half of the members are chloride channels, while the other half are chloride-proton antiporters.

In the bioindustry, the real challenge in developing therapeutics based on ion-channel research is the size of ion-channel families and their widespread distribution. The ongoing focus for the development of therapeutics with channel specificity is to develop subtype selectivity to improve efficacy and reduce the impact of side effects.

At Devgen, the focus is on treatment for inflammatory and metabolic diseases and arrhythmia. Petra Blom, PhD, section leader within the medicinal chemistry group, and Titus Kaletta, PhD, head of preclinical development, are working on a project targeting the Kv4.3 ion channel. The goal of their work is to develop a first-in-class oral treatment for acute and chronic atrial fibrillation.

Also discussed in the GEN article is ion-channel work at Organon Laboratories, ChanTest, Molecular Devices and Axon Instruments (both now part of MDS Analytical Technologies), Sophion Bioscience, Nanion Technologies, and Flyion.

For a copy of the June 1 issue of GEN, please call 914.740.2122, or email: ebicovny@liebertpub.com

Genetic Engineering and Biotechnology News (http://www.genengnews.com), which is published 21 times a year by Mary Ann Liebert, Inc., is the most widely read biotechnology news magazine worldwide. It includes articles on Drug Discovery, Bioprocessing, OMICS, Biobusiness, and Clinical Research and Diagnostics.

Contact: John Sterling

Editor in Chief

Genetic Engineering & Biotechnology News

914.740.2196

jsterling@genengnews.com


'/>"/>
SOURCE Genetic Engineering & Biotechnology News
Copyright©2008 PR Newswire.
All rights reserved

Related medicine technology :

1. CellCyte Genetics Corporation Selects Washington University School of Medicine to Perform Study on CellCytes Glycoprotein Products in Heart Attack Disease Model
2. Presentation of Data on Progens Cancer Epigenetic Targets Platform
3. CellCyte Genetics Signs Collaborative Agreement With Northwestern Universitys Feinberg School of Medicine to Perform Disease Model Outcome Study of CellCytes CCG-TH30 Product Candidate
4. Join NPRs David Ewing Duncan, Author Jessica Queller and a Panel of Medical and Legal Experts in a 90-Minute Webcast on Genetic Testing, Genomic Medicine and Breast & Ovarian Cancer
5. deCODE Discovers Novel Genetic Links Between Pigmentation Traits and Risk of Skin Cancer
6. Video: The Journal, Human Genetics, Publishes Results Supporting Interleukin Genetics Heart Health Test
7. Genetic Immunity Announces Data Related to the DermaVir Nanomedicine Patch in the Journal of Immunology
8. Preclinical Study Shows CTIs Brostallicins Cancer-Killing Ability Based on Genetic Profiling
9. Genzyme Genetics Announces Launch of Carrier Testing and Prenatal Diagnosis for Spinal Muscular Atrophy
10. Navigenics(TM) Genome Analysis Used In Research Trial on the Impact of Providing Genetic Risk Assessments
11. Ranolazine Shortens QT Interval and Improves Cardiac Relaxation in Study of Patients With Genetic Sodium Channel Disorder
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2016)... 24, 2016 Dutch surgeons have launched a ... the world and treat patients on a global scale. Medical professionals ... Asia and the US have already signed ... and networking in a totally secure environment. Education  ... zone working together with a surgeon at Harvard to treat a ...
(Date:5/23/2016)... , May 23, 2016 Global ... 163 pages, profiles 12 companies and the Paclitaxel analysis ... figures on the industry and its players. ... comprehensive in nature, details the current state of the ... including definitions, classifications, applications and industry chain structure. The ...
(Date:5/23/2016)... , May 23, 2016 ... Size, Share, Development, Growth and Demand Forecast to ... and Other), by Application (Drug Discovery and Development, ... Users (Pharmaceuticals, Life Science and Biotechnology, Academic and ... Market Research, the global mass spectrometry market ...
Breaking Medicine Technology:
(Date:5/26/2016)... ... May 26, 2016 , ... With long-term experience in ... of Business Intelligence and Informatics, effective immediately. http://www.fluidedgeconsulting.com , As a ... a healthcare business and financial strategist for over 20 years. By leveraging ...
(Date:5/25/2016)... (PRWEB) , ... May 26, 2016 , ... The United ... treatment of androgenetic alopecia in both men and women. To date, the company is ... with FDA clearance for any adult who suffers with androgenetic alopecia. , “This ...
(Date:5/25/2016)... ... May 25, 2016 , ... ... Association's Get With The Guidelines®-Stroke Gold Plus Achievement Award with Target: StrokeSM ... Memorial Healthcare System, recognizes its commitment to emergency stroke care to ensure ...
(Date:5/25/2016)... ... May 25, 2016 , ... ... and Tennessee locations to streamline patient check-in and post visit surveys. , “The ... to patient care. It has revolutionized the check-in process for our clinic network, ...
(Date:5/25/2016)... ... May 25, 2016 , ... Furthering its position as the industry leader in ... Drug Free Sport (Drug Free Sport®) is excited to expand on details of its ... 12 – 13 in Kansas City, MO, will gather sports industry professionals to examine, ...
Breaking Medicine News(10 mins):